These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The march toward rational therapeutics in children. Gorman RL Pediatr Infect Dis J; 2003 Dec; 22(12):1119-23. PubMed ID: 14688584 [TBL] [Abstract][Full Text] [Related]
28. Hormones: androgens, antiandrogens, anabolic steroids, estrogens--unapproved uses or indications. Güneş AT; Fetil E Clin Dermatol; 2000; 18(1):55-61. PubMed ID: 10701086 [No Abstract] [Full Text] [Related]
29. Vitamins A, B, C, D, E, F, trace elements and heavy metals: unapproved uses or indications. Nicolaidou E; Katsambas AD Clin Dermatol; 2000; 18(1):87-94. PubMed ID: 10701089 [No Abstract] [Full Text] [Related]
30. Unapproved drugs in the United States and the Food and Drug Administration. Nasr A; Lauterio TJ; Davis MW Adv Ther; 2011 Oct; 28(10):842-56. PubMed ID: 21894470 [TBL] [Abstract][Full Text] [Related]
31. The FDA drug approval process: focus on pediatric labeling. Brummel GL Neonatal Netw; 2001 Apr; 20(3):49-51. PubMed ID: 12144214 [No Abstract] [Full Text] [Related]
33. Unapproved drugs--the drug information pharmacists' perspective. Giouroukakis M; Dryer M J Pharm Pract; 2013 Apr; 26(2):112-9. PubMed ID: 23459285 [TBL] [Abstract][Full Text] [Related]
34. Phototherapy, photochemotherapy, and photodynamic therapy: unapproved uses or indications. Ledo E; Ledo A Clin Dermatol; 2000; 18(1):77-86. PubMed ID: 10701088 [No Abstract] [Full Text] [Related]
35. IOM Review of FDA--approved biologics labeled or studied for pediatric use. Field MJ; Ellinger LK; Boat TF Pediatrics; 2013 Feb; 131(2):328-35. PubMed ID: 23319521 [TBL] [Abstract][Full Text] [Related]
36. Off-label uses of biologic agents in dermatology: a 2006 update. Kerns MJ; Graves JE; Smith DI; Heffernan MP Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843 [TBL] [Abstract][Full Text] [Related]
37. The risks of pharmacological therapy for insomnia (part 1): update for the clinical nurse specialist. O'Malley P Clin Nurse Spec; 2007; 21(4):188-90. PubMed ID: 17622806 [No Abstract] [Full Text] [Related]
38. Unapproved uses of approved drugs. Coté CJ Paediatr Anaesth; 1997; 7(2):91-2. PubMed ID: 9188107 [No Abstract] [Full Text] [Related]
39. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs. Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390 [TBL] [Abstract][Full Text] [Related]
40. Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications. Koo JY; Ng TC Clin Dermatol; 2002; 20(5):582-94. PubMed ID: 12435529 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]